← Eichor
Study identifier: NCT02748941 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control

Condition: Carotid Stenosis  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants77
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Cerebrovascular accident (CVA) constitutes a major health public problem. This represents the second cardiovascular death cause. CVA is ischemic in 80% of cases. Atheroma of large arteries, mainly carotid, is involved in about 20% of cases. After several high grade studies (NASCET, ECST, ACAS, ACST), carotid surgery is based on stenosis calculation by Doppler ultrasound, CT angiography, MRI angiography or arteriography. The composition of the plaque, showing its vulnerability, is associated with embolic risk and stroke. The therapeutic strategy based only on the narrowing of the arterial lumen is not satisfactory enough to prevent the occurrence of a transient ischemic attack (TIA) or an ipsilateral stroke due to carotid stenosis. Thus, new techniques emerge, to evaluate in vivo the inflammation of the plaque, its embolic consequences or the mechanical stress it undergoes. These techniques are: High Resolution MRI (HR MRI), evaluation of the Gray Scale Median (GSM) level, study of the plaque vascularization with Contrast Enhanced ultrasound (CEUS), High Intensity Transient Signals (HITS) by transcranial Doppler, micro RNA profile (mi RNA). These different modalities must be combined in order to increase the efficiency. Based on these encouraging results, the investigator aim at evaluating the ability of different methods or their combination to predict the occurrence of ischemic stroke or TIA due to emboli from a carotid atherosclerotic plaque. Before considering a cohort …

This description comes directly from the study's public registry record.

Talk to the study team

Philippe DOUEK, MD  ·  (0)472357233  ·  philippe.douek@chu-lyon.fr

Adeline MANSUY, CRA  ·  (0)4 72 11 5225  ·  adeline.mansuy@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hospices Civils de Lyon - Service de radiologieBron, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02748941